Exome Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Exome Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-117,500	Closed	-$1.55M	–	77
2025 Q1	$1.55M	Hold	117,500	–	–	1.38%	33
2024 Q4	$1.86M	Sell	117,500 -64,000	-35%	-$961K	1.39%	31
2024 Q3	$2.88M	Hold	181,500	–	–	1.95%	23
2024 Q2	$2.77M	Sell	181,500 -248,500	-58%	-$3.56M	2.46%	15
2024 Q1	$6.31M	Sell	430,000 -20,000	-4%	-$292K	5.4%	2
2023 Q4	$6.26M	Buy	+450,000	New	+$6.02M	6.19%	1

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Exome Asset Management's RDY Position: Q2 2025 in Review

Exome Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 117,500 shares — an estimated $1.55M sold.

Exome Asset Management first reported a position in RDY in Q4 2023 and held it in 6 quarters. The position peaked at $6.31M in Q1 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

Exome Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
Exome Asset Management sold 117,500 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $1.55M.
Exome Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2023 and held it in 6 quarters.
Exome Asset Management's Dr. Reddy's Laboratories position peaked at $6.31M in Q1 2024.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Exome Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.